The Fondation pour la science is a non-profit, private entity. Its aim is to promote the Weizmann Institute of Science in Belgium and to support its research projects via appropriate public relations activities as well as selective fund raising, in particular in the form of sponsorships, donations and legacies.

One of the Foundation’s regular activites is the sponsoring of promising students attending Belgian secondary schools, who qualify for participation in the annual 4 weeks International Scientific Summer School (ISSI) on the Weizmann Institute of Science campus, before continuing their tertiary education in science. This year two promising young women have been selected.

The Foundation is chaired by Mr Christian Hendboeg.
Mrs Diane Culer, Prof. Pierre Klees, Prof Maurice Sosnowski, Mr Paul de Schietere de Lophem, Mr Eric Hemeleers and Mr Roland Louis are directors.
The Belgian Foundation was founded in 2006, replacing the Belgian Committee, which had been established in 1973 by Prof. Georges Schnek, who also served as the first Secretary General until 1979. He was succeeded by Mr Louis Culer, who held this position for 20 years until 1999, followed by Prof. Marc van Montagu until June 2006.

Among the former Chairmen of the Committee were the former Belgian Prime Minister Theo Lefèvre (1973-1975), Prof. Piet de Somer, Rector of the “Katolieke Universiteit Leuven” (1975-1980) and Prof. Jean Brachet (1980-1972). Two Nobel Laureates, Prof. Christian de Duve and Prof. Ilya Prigogine, were members of the Academic Council.

An Exception to the Rule: An Intact Sense of Smell without a Crucial Olfactory Brain Structure

A handful of left-handed women have excellent senses of smell, despite lacking olfactory bulbs

Computer-enhanced MRI images of the brains of left-handed women found two that were missing olfactory bulbs

Five papers in one week published in the Proceedings of the National Academy of Sciences highlight Weizmann Institute research

5 in PNAS

1 – An investigation into the way that double-stranded DNA unwinds for replication, repair or transcription, coauthored by Prof. Yaakov Levy of the Structural Biology Department, together with researchers in Italy, the UK and Spain. By combining simulations and experiments, physics, chemistry and biology, this work reveals that asymmetric base pair dynamics drive the stepwise separation of nucleic acid duplexes. The data suggest a layer of regulation of the genetic material encoded in the “unwindability” of the double helix.

Ebola Antibodies at Work

Scientists in Israel and Germany show, on the molecular level, how an experimental vaccine offers long-term protection against the disease


The glycoprotein spike complex of the Ebola virus bound by a neutralizing antibody isolated from a vaccinated individual. Surface representations in grey and pink show the two distinct submits that make the trimeric Ebola spike complex. The heavy and light chains of the neutralizing antibody are shown as blue and green ribbons, respectively. The antibody neutralizes this complex by stapling two adjacent subunits and preventing conformational changes needed by the virus to enter the host cell

The Basic Bacterial Defense

A newly-discovered immune system in bacteria is the distance ancestor of one in our own cell


E coli with and without active CBASS defenses against viral infection. Between 40 min. and and hour, those with active systems (l) committed suicide; while after an hour, those without (r) succumbed and released their viral load

Cancer Protocols: A New Approach to Predicting Treatment Outcomes

Weizmann Institute of Science research shows heterogeneity in melanoma tumors prevents effective immune responses


Diversity – at least among cancer cells – is not a good thing. Weizmann Institute of Science research shows that in melanoma, tumors with cells that have differentiated into more diverse subtypes are less likely to be affected by the immune system, thus reducing the chance that immunotherapy will be effective. The findings of this research, which were published today in Cell, may provide better tools for designing personalized protocols for cancer patients, as well as pointing toward new avenues of research into anti-cancer vaccines.